In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria

Antimicrob Agents Chemother. 2010 May;54(5):2188-90. doi: 10.1128/AAC.01603-09. Epub 2010 Mar 15.

Abstract

In this work, we describe the activity of ACH-702 against clinical isolates of Mycobacterium tuberculosis and six different nontuberculous mycobacteria. The MIC(50) and MIC(90) of both susceptible and drug-resistant M. tuberculosis strains tested were 0.0625 and 0.125 microg/ml, respectively. The MIC(50) and MIC(90) values for Mycobacterium fortuitum isolates were 0.0625 microg/ml in both cases; Mycobacterium avium complex isolates showed MIC(50) and MIC(90) values of 0.25 and 4 microg/ml, respectively.

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Drug Design
  • Drug Resistance, Bacterial / drug effects*
  • In Vitro Techniques
  • Microbial Sensitivity Tests
  • Mycobacterium avium / drug effects*
  • Mycobacterium avium Complex / drug effects
  • Mycobacterium chelonae / drug effects
  • Mycobacterium fortuitum / drug effects
  • Mycobacterium kansasii / drug effects
  • Mycobacterium tuberculosis / drug effects*
  • Nontuberculous Mycobacteria / drug effects
  • Quinolones / pharmacology*
  • Thiazoles / pharmacology*

Substances

  • ACH 702
  • Antitubercular Agents
  • Quinolones
  • Thiazoles